In the vehicle-treated group, BAFF levels significantly increased to compensate for impaired B lymphopoiesis, which may be associated with an increase in GC B cells that produce pathological immunoglobulins for chronic GVHD development. This evidence concerns the gene TNFSF13B and chronic graft versus host disease.